ECSCR and neoplasm: Also down regulated in PC3 holoclones was the endothelial cell-specific chemotaxis regulator ECSCR, which when knocked down in tumor xenografts leads to an increase in angiogenesis [62] and could contribute to the increased vascularity seen in the PC3 holoclone-derived tumors.